Audrey Kunin - 30 Nov 2021 Form 4 Insider Report for NovaBay Pharmaceuticals, Inc. (NBY)

Role
Chief Product Officer
Signature
/s/ Audrey Kunin
Issuer symbol
NBY
Transactions as of
30 Nov 2021
Net transactions value
+$13,800
Form type
4
Filing time
02 Dec 2021, 15:30:20 UTC
Previous filing
24 Nov 2021
Next filing
03 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBY Common Stock Purchase $13,800 +30,000 +33% $0.4600 121,133 30 Nov 2021 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 By The Audrey G. Kunin Trust in which the reporting person serves as the trustee and has investment control.